Clinical Trial

A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

Name: A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment — clinical trial record (NCT07231029)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

An open-label study to evaluate the effect of TS-172 administration on pharmacokinetics in patients with hepatic impairment

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-11-13; most recent amendment 2026-01-07.

Status change: Not Yet Recruiting → Recruiting 2025-12-03

Trial Details

NCT Number	NCT07231029
Lead Sponsor	Taisho Pharmaceutical Co., Ltd.
Conditions	Patients With Mild or Moderate Hepatic Impairment
Enrollment	24 participants
Start Date	2025-12-23
Primary Completion	2026-10-26 (estimated)
Study Completion	2026-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-09